A consortium to improve data strategies for treating sickle cell disease
Data Strategy Consortium for the NHLBI Cure Sickle Cell Initiative
This study is working to gather and analyze information to improve treatments for sickle cell disease, so that patients can benefit from better care and new therapies tailored just for them.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Research Triangle Institute NIH-funded |
| Lab location | 1 site (Research Triangle Park, United States) |
| Project ID | NIH-10021174 on NIH RePORTER |
What this research studies
This research focuses on developing a comprehensive data strategy to enhance the understanding and treatment of sickle cell disease. By collaborating with various stakeholders, including researchers and healthcare providers, the initiative aims to collect and analyze data that can inform clinical trials and improve patient outcomes. The approach includes utilizing genomic and genetic therapies to explore innovative treatment options for individuals affected by this condition. Patients may benefit from advancements in treatment protocols and personalized care based on the findings from this consortium.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with sickle cell disease or related hemoglobin disorders.
Not a fit: Patients with conditions unrelated to sickle cell disease may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options and better management strategies for patients with sickle cell disease.
How similar studies have performed: Other research initiatives focusing on data strategies and genomic therapies for sickle cell disease have shown promise, indicating potential for success in this approach.
Where this research is happening
Research Triangle Park, United States
- Research Triangle Institute — Research Triangle Park, United States (Active)
Researchers
- Principal investigator: Kroner, Barbara L — Research Triangle Institute
- Study coordinator: Kroner, Barbara L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.